Our current food system is facing a myriad of critical challenges. The United Nations predicts that the world population will ...

A collaborative effort between investigators at the National Institutes of Health's National Institute of Allergy and ...

In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of ...

A collaborative effort between investigators at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and Massachusetts General Hospital (MGH), a founding ...

SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread ...

In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of ...

In March 2023, the Organising Committee of the Third International Summit on Human Genome Editing published a statement ...

A $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at the University of Pennsylvania (Penn) and Children's Hospital of ...

With Gene Editing, Mice With a Form of Inherited Deafness Can Hear Again July 12, 2024 — Researchers have used gene editing to restore hearing in adult mice with a type of inherited hearing loss.

The global gene editing tool market is expected to surge at a compound annual growth rate (CAGR) of 18.4% from 2024 to 2034, exceeding the previous growth rate of 17.4% (2019-2023). The market value ...

The results provide the first clinical evidence of RNA editing, a burgeoning field that's drawn interest from biotechs and pharmaceutical companies alike.